SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Biogen had a major disappointment recently regarding their

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Reyeton Member Profile
 
Followed By 11
Posts 556
Boards Moderated 0
Alias Born 04/13/13
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/14/2017 5:15:55 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/11/2017 5:22:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/11/2017 4:42:04 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/7/2017 4:41:07 PM
Anavex Reports Fiscal Third Quarter 2017 Financial Results "GlobeNewswire Inc." - 8/7/2017 7:00:00 AM
Anavex Life Sciences Appoints Distinguished Researcher in Neurology and Epilepsy to Scientific Advisory Board "GlobeNewswire Inc." - 7/20/2017 7:00:00 AM
Pharmaceutical Leaders Pave the Way to New Alzheimer’s Treatments "NetworkNewsWire" - 6/15/2017 7:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 6/13/2017 6:03:09 AM
Anavex Life Sciences to Present at Jefferies 2017 Global Healthcare Conference "GlobeNewswire Inc." - 6/5/2017 7:00:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 5/26/2017 4:32:21 PM
Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome: Data Prese... "GlobeNewswire Inc." - 5/22/2017 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:54:40 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:54:40 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/10/2017 4:29:05 PM
Anavex Reports Fiscal Second Quarter 2017 Financial Results "GlobeNewswire Inc." - 5/10/2017 7:00:00 AM
Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs "GlobeNewswire Inc." - 5/1/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/21/2017 6:09:35 AM
Positive News in the Fight against Cancer Fuels Quest for More Good Tidings "NetworkNewsWire" - 4/18/2017 8:45:00 AM
Anavex Life Sciences Reports New Mechanism of Action Data Related to ANAVEX Compounds Targeting Sigma-1 Receptor "GlobeNewswire Inc." - 4/3/2017 7:00:00 AM
Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit "GlobeNewswire Inc." - 3/30/2017 8:00:00 AM
Anavex Life Sciences to Present at the 13th International Conference on Alzheimer's and Parkinson's Diseases AD/PD™ 2017 "GlobeNewswire Inc." - 3/29/2017 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 3/17/2017 6:06:45 AM
Anavex Life Sciences to Present at Oppenheimer 27th Annual Healthcare Conference "GlobeNewswire Inc." - 3/15/2017 7:00:00 AM
Anavex Life Sciences to Present at 14th Annual BIO Asia International Conference "GlobeNewswire Inc." - 3/13/2017 7:00:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 3/10/2017 7:17:05 AM
Reyeton   Saturday, 08/12/17 07:31:33 PM
Re: tradeherpete post# 115235
Post # of 115864 
Biogen had a major disappointment recently regarding their anti-lingo drug expected to restore mylen. It seems possible they are waiting for the Plus patent before teaming with us. If the patent is broad enough and allows linking A273 with drugs other than aricept, it seems that's what will bring them on board with us, hopefully a sizable initial lump sum and 50/50 partnership for MS. Stranger things have happened.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist